No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study

MLA

Benoît Pilmis, et al. “No Significant Difference between Ceftriaxone and Cefotaxime in the Emergence of Antibiotic Resistance in the Gut Microbiota of Hospitalized Patients: A Pilot Study.” International Journal of Infectious Diseases, vol. 104, no. 617–623, Mar. 2021, pp. 617–23. EBSCOhost, https://doi.org/10.1016/j.ijid.2021.01.025.

APA

Benoît Pilmis, Olivier Jiang, Assaf Mizrahi, Jean-Claude Nguyen Van, Julie Lourtet-Hascoët, Olivier Voisin, Erwan Le Lorc’h, Sidonie Hubert, Elodie Ménage, Philippe Azria, Marie-Françoise Borie, Annabelle Mahé, Jean-Jacques Mourad, Eloïse Trabattoni, Olivier Ganansia, Jean-Ralph Zahar, & Alban Le Monnier. (2021). No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study. International Journal of Infectious Diseases, 104(617–623), 617–623. https://doi.org/10.1016/j.ijid.2021.01.025

Chicago

Benoît Pilmis, Olivier Jiang, Assaf Mizrahi, Jean-Claude Nguyen Van, Julie Lourtet-Hascoët, Olivier Voisin, Erwan Le Lorc’h, et al. 2021. “No Significant Difference between Ceftriaxone and Cefotaxime in the Emergence of Antibiotic Resistance in the Gut Microbiota of Hospitalized Patients: A Pilot Study.” International Journal of Infectious Diseases 104 (617–623): 617–23. doi:10.1016/j.ijid.2021.01.025.